Discontinuation of Dual Antiplatelet Therapy Over 12 Months after Acute Coronary Syndromes Increases Risk for Adverse Events in Patients Treated with Percutaneous Coronary Intervention: Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Discontinuation of Dual Antiplatelet Therapy Over 12 Months after Acute Coronary Syndromes Increases Risk for Adverse Events in Patients Treated with Percutaneous Coronary Intervention: Systematic Review and Meta-Analysis

Published:2014-03-14 Issue:3 Volume:27 Page:233-241
ISSN:0896-4327
Container-title:Journal of Interventional Cardiology
language:en
Short-container-title:J. Int. Cardiol.

Author:

D'ASCENZO FABRIZIO¹²,COLOMBO FRANCESCO¹,BARBERO UMBERTO¹,MORETTI CLAUDIO¹²,OMEDÈ PIERLUIGI¹,REED MATTHEW J.³,TARANTINI GIUSEPPE⁴,FRATI GIACOMO⁵,DI NICOLANTONIO JAMES J.⁶,BIONDI ZOCCAI GIUSEPPE²⁵,GAITA FIORENZO¹

Affiliation:

1. Division of Cardiology; University of Turin; Città Della Salute e Delle Scienze San Giovanni Battista; Turin Italy

2. Meta-analysis and Evidence Based Medicine Training in Cardiology (METCARDIO); Wegmans Pharmacy Ithaca; Ithaca New York

3. Department of Emergency Medicine; Edinburgh UK

4. Division of Cardiology, Department of Cardiac; Thoracic and Vascular Sciences, University of Padova; Padova Italy

5. Department of Medico-Surgical Sciences and Biotechnologies; Sapienza University of Rome; Laina Italy

6. Mid America Heart Institute; Saint Luke's Hospital; Kansas City Missouri

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/joic.12107/fullpdf

Reference48 articles.

1. Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes;Biondi-Zoccai;Int J Cardiol,2011

2. Prasugrel during primary percutaneous coronary intervention: Evidence from clinical data;Biondi-Zoccai;Curr Vasc Pharmacol,2012

3. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation;Yusuf;N Engl J Med,2001

4. Prasugrel versus clopidogrel in patients with acute coronary syndromes;Wiviott;N Engl J Med,2007

5. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N Engl J Med,2009

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Clinical Presentation on Outcomes After Rotational Atherectomy in Patients Who Underwent Percutaneous Coronary Intervention;The American Journal of Cardiology;2023-08

2. Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial;Journal of Thrombosis and Thrombolysis;2021-04-13

3. Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study);BMC Cardiovascular Disorders;2020-05-15

4. Oral antiplatelet therapy in the elderly undergoing percutaneous coronary intervention: an umbrella review;Journal of Thoracic Disease;2020-04

5. Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations;The American Journal of Cardiology;2020-02